Issue 27, 2021

Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties

Abstract

In this paper it is demonstrated that the nature of the ligands of two Ru2(II,III) paddlewheel complexes dramatically affects the overall anticancer properties in cells. Herein, the complex [Ru2(EB776)4Cl] was found to be more active against a glioblastoma model with respect to its isomer [Ru2(EB106)4Cl]. These different effects depend on the steric hindrance, on the allowed conformations of the complexes and on the presence of hydrophilic regions in [Ru2(EB776)4Cl], which overall lead to a lower “steric protection”.

Graphical abstract: Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties

Supplementary files

Article information

Article type
Paper
Submitted
07 May 2021
Accepted
03 Jun 2021
First published
03 Jun 2021

Dalton Trans., 2021,50, 9643-9647

Two mixed valence diruthenium(II,III) isomeric complexes show different anticancer properties

E. Barresi, I. Tolbatov, T. Marzo, E. Zappelli, A. Marrone, N. Re, A. Pratesi, C. Martini, S. Taliani, F. Da Settimo and D. La Mendola, Dalton Trans., 2021, 50, 9643 DOI: 10.1039/D1DT01492G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements